Literature DB >> 23049202

Author's reply.

Atul Bhardwaj1, Manoj Tanwar.   

Abstract

Entities:  

Year:  2012        PMID: 23049202      PMCID: PMC3456855     

Source DB:  PubMed          Journal:  Ayu        ISSN: 0974-8520


× No keyword cloud information.
Thank you sir for showing interest in the article[1] and raising certain queries. Since it is a a preliminary study, only a limited number of cases have been enrolled in the current attempt. A clinical trial with a large number of population has already been done. The observations are under the process of publication. Regarding the scoring system; Visual Analogue Scale (VAS) is adopted for the trial as universal grading and scoring system consensus is difficult to find. Aseptic conditions were ascertained while manufacturing and storing the eye drops. Analysis of the trial drugs revealed that the drugs are free from microbial contaminations. Hence, they are safe to use as eye drops.[2]
  2 in total

1.  Effect of rasanjana madhu ashchyotana in netra abhishyanda (mucopurulent conjunctivitis).

Authors:  Atul Bhardwaj; Manoj Tanwar
Journal:  Ayu       Date:  2011-07

2.  Rasanjana Madhu Ashchyotana for a mucopurulent conjunctivitis.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Ayu       Date:  2012-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.